Methylation status of nine tumor suppressor genes in multiple myeloma

International Journal of Hematology

Volumn 91, Issue 1, 2010, Pages 87-96

  Braggio, Esteban ^a   Maiolino, Angelo ^b   Gouveia, Maria E ^a   Magalhães, Roberto ^b   Souto Filho, João T ^b   Garnica, Márcia ^b   Nucci, Marcio ^b   Renault, Ilana Zalcberg ^c  

^a INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c Bone Marrow Transplantation Centre   (Brazil)

Author keywords

DAPK; Hypermethylation; MSP; Multiple myeloma

Indexed keywords

DEATH ASSOCIATED PROTEIN KINASE; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; PROTEIN BNIP3; PROTEIN TYROSINE PHOSPHATASE SHP 1; UVOMORULIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; FEMALE; FOLLOW UP; GENE SILENCING; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; POLYMERASE CHAIN REACTION; PROGNOSIS; TUMOR SUPPRESSOR GENE; UNIVARIATE ANALYSIS;

ADULT; AGED; APOPTOSIS REGULATORY PROTEINS; CADHERINS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASES; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA METHYLATION; DNA MODIFICATION METHYLASES; DNA REPAIR ENZYMES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENES, TUMOR SUPPRESSOR; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MULTIPLE MYELOMA; PROGNOSIS; PROMOTER REGIONS, GENETIC; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 6; PROTO-ONCOGENE PROTEINS; RECEPTORS, ESTROGEN; RECEPTORS, RETINOIC ACID; TUMOR SUPPRESSOR PROTEINS;

EID: 75049085509     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-009-0459-2     Document Type: Article

References (40)

1. RA Kyle SV Rajkumar 2004 Multiple myeloma N Engl J Med 351 1860 1873 10.1056/NEJMra041875 1:CAS:528:DC%2BD2cXptFChtLk%3D 15509819 (Pubitemid 39426321)
2. Ries LAG, Eisner MP, Kosary CL. SEER cancer statistics review 1975-2001. National Cancer Institute; 2004.
3. NV Smadja C Fruchart F Isnard C Louvet JL Dutel N Cheron, et al. 1998 Chromosomal analysis in multiple myeloma: cytogenetic evidence of two different diseases Leukemia 12 960 969 10.1038/sj.leu.2401041 1:STN:280: DyaK1czgtFaqtQ%3D%3D 9639426
4. C Debes-Marun G Dewald S Bryant E Picken R Santana-Dávila N González-Paz, et al. 2003 Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma Leukemia 17 427 436 10.1038/sj.leu.2402797 1:STN:280:DC%2BD3s%2FotVCmuw%3D%3D 12592343 (Pubitemid 36266921)
5. R Fonseca B Barlogie R Bataille C Bastard PL Bergsagel M Chesi, et al. 2004 Genetics and cytogenetics of multiple myeloma: a workshop report Cancer Res 64 1546 1558 10.1158/0008-5472.CAN-03-2876 1:CAS:528:DC%2BD2cXhtleitb4%3D 14989251 (Pubitemid 38235629)
6. R Fonseca CS Debes-Marun EB Picken GW Dewald SC Bryant JM Winkler, et al. 2003 The recurrent IgH translocations are highly associated with nonhyperdiploid variant multiple myeloma Blood 102 2562 2567 10.1182/blood-2003-02-0493 1:CAS:528:DC%2BD3sXnslykur8%3D 12805059 (Pubitemid 37193596)
7. NV Smadja D Leroux J Soulier S Dumont C Arnould S Taviaux, et al. 2003 Further cytogenetic characterization of multiple myeloma confirms that 14q32 translocations are a very rare event in hyperdiploid cases Gene Chromosome Cancer 38 234 239 10.1002/gcc.10275 (Pubitemid 37259640)
8. P Bergsagel M Kuehl 2003 Critical roles for immunoglobulin translocations and cyclin D dysregulation in multiple myeloma Immunol Rev 194 96 104 10.1034/j.1600-065X.2003.00052.x 1:CAS:528:DC%2BD3sXmsV2ms7w%3D 12846810 (Pubitemid 36886431)
9. PL Bergsagel M Kuehl F Zhan J Sawyer B Barlogie J Shaughnessy 2005 Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma Blood 106 296 303 10.1182/blood-2005-01-0034 1:CAS:528:DC%2BD2MXlvVWjtrs%3D 15755896 (Pubitemid 40967205)
10. P Laird R Jaenisch 1994 DNA methylation and cancer Hum Mol Genet 3 1487 1495 1:CAS:528:DyaK2cXmsVOhtrc%3D 7849743
11. P Jones S Baylin 2002 The fundamental role of epigenetic events in cancer Nat Rev Genet 3 415 428 10.1038/nrg962 1:CAS:528:DC%2BD38XksFOmsrw%3D 12042769
12. M Ng W To KW Lo S Chan KS Tsang SH Cheng, et al. 2001 Frequent death-associated protein kinase promoter hypermethylation in multiple myeloma Clin Cancer Res 7 1724 1729 1:CAS:528:DC%2BD3MXltV2hs7g%3D 11410512
13. M Mateos R García-Sanz R López-Pérez M Moro E Ocio J Hernández, et al. 2002 Methylation is an inactivating mechanism of the p16 gene in multiple myeloma associated with high plasma cell proliferation and short survival Br J Haematol 118 1034 1040 10.1046/j.1365-2141.2002.03749.x 1:CAS:528:DC%2BD38Xotlanurg%3D 12199782 (Pubitemid 35025966)
14. G Guillerm S Depil D Wolowiec B Quesnel 2003 Different prognostic values of p15INK4b and p16INK4a in multiple myeloma Haematologica 88 476 478 12681979
15. CS Chim YL Kwong TK Fung R Liang 2004 Methylation profiling in multiple myeloma Leuk Res 28 379 385 10.1016/j.leukres.2003.08.008 1:CAS:528: DC%2BD2cXhtFWitb4%3D 15109538 (Pubitemid 38199946)
16. C Chim T Fung W Cheung R Liang Y Kwong 2004 SOCS1 and SHP1 hypermethylation in multiple myeloma: implications for epigenetic activation of the Jak/STAT pathway Blood 103 4630 4635 10.1182/blood-2003-06-2007 1:CAS:528:DC%2BD2cXlt1Krt7c%3D 14976049 (Pubitemid 38745995)
17. O Galm S Wilop J Reichelt E Jost G Gehbauer J Herman, et al. 2004 DNA methylation changes in multiple myeloma Leukemia 18 1687 1692 10.1038/sj.leu.2403434 1:CAS:528:DC%2BD2cXnvV2qsL0%3D 15318245 (Pubitemid 39386348)
18. D Rossi D Capello A Gloghini S Franceschetti M Paulli K Bhatia, et al. 2004 Aberrant promoter methylation of multiple genes throughout the clinico-pathologic spectrum of B-cell neoplasia Haematologica 89 154 164 1:CAS:528:DC%2BD2cXotlSrtrY%3D 15003890
19. S Seidl J Ackermann H Kaufmann A Keck T Nösslinger C Zielinski, et al. 2004 DNA-methylation analysis identifies the E-cadherin gene as a potential marker of disease progression in patients with monoclonal gammopathies Cancer 100 2598 2606 10.1002/cncr.20295 1:CAS:528:DC%2BD2cXlsFChs70%3D 15197802 (Pubitemid 38715765)
20. N Gonzalez-Paz W Chng R McClure E Blood M Oken B Van Ness, et al. 2007 Tumor suppressor p16 methylation in multiple myeloma: biological and clinical implications Blood 109 1228 1232 10.1182/blood-2006-05-024661 1:CAS:528:DC%2BD2sXjtFertb8%3D 16840723 (Pubitemid 46220672)
21. B Durie S Salmon 1975 A clinical staging sytem for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival Cancer 36 842 854 10.1002/1097-0142(197509) 36:3<842::AID-CNCR2820360303>3.0.CO;2-U 1:STN:280:DyaE28%2FktFCqtA%3D%3D 1182674
22. The International Myeloma Working Group 2003 Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group Br J Haematol 121 749 757 10.1046/j.1365-2141.2003.04355.x (Pubitemid 36718191)
23. J Herman J Graff S Myohanen B Nelkin S Baylin 1996 Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands Proc Natl Acad Sci USA 93 9821 9826 10.1073/pnas.93.18.9821 1:CAS:528:DyaK28XlsFeht7Y%3D 8790415 (Pubitemid 26296693)
24. J Graff J Herman S Myohanen S Baylin P Vertino 1997 Mapping patterns of CpG island methylation in normal and neoplastic cells implicates both upstream and downstream regions in de novo methylation J Biol Chem 272 22322 22329 10.1074/jbc.272.35.22322 1:CAS:528:DyaK2sXlslOls7o%3D 9268383 (Pubitemid 27382868)
25. R Lapidus S Nass K Butash F Parl S Weitzman J Graff, et al. 1998 Mapping of ER gene CpG island methylation-specific polymerase chain reaction Cancer Res 58 2515 2519 1:CAS:528:DyaK1cXktVajt7w%3D 9635570
26. R Katzenellenbogen S Baylin J Herman 1999 Hypermethylation of the DAPKinase CpG islands is a common alteration in B cell malignancies Blood 93 4347 4353 1:CAS:528:DyaK1MXjvVGrtLc%3D 10361133
27. T Oka M Ouchida M Koyama 2002 Gene silencing of the tyrosine phosphatase SHP1 gene by aberrant methylation in leukemias/lymphomas Cancer Res 62 6390 6394 1:CAS:528:DC%2BD38XovFOlur4%3D 12438221
28. M Esteller J Garcia-Foncillas E Andion S Goodman O Hidalgo V Vanaclocha, et al. 2000 Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents N Engl J Med 343 1350 1354 10.1056/ NEJM200011093431901 1:CAS:528:DC%2BD3cXosFOltLg%3D 11070098 (Pubitemid 30826035)
29. M Esteller G Gaidano S Goodman V Zagonel D Capello B Botto, et al. 2002 Hypermethylation of the DNA repair gene O(6)-methylguanine DNA methyltransferase and survival of patients with diffuse large B-cell lymphoma J Natl Cancer Inst 94 26 32 1:CAS:528:DC%2BD38Xit1amt7Y%3D 11773279
30. T Takahashi N Shivapurkar J Reddy H Shigematsu K Miyajima M Suzuki, et al. 2004 DNA methylation profiles of lymphoid and hematopoietic malignancies Clin Cancer Res 10 2928 2935 10.1158/1078-0432.CCR-03-0716 1:CAS:528: DC%2BD2cXjs12lsLw%3D 15131027 (Pubitemid 38619667)
31. M Murai M Toyota A Satoh H Suzuki K Akino H Mita, et al. 2005 Aberrant DNA methylation associated with silencing BNIP3 gene expression in haematopoietic tumours Br J Cancer 92 1165 1172 10.1038/sj.bjc.6602422 1:CAS:528:DC%2BD2MXisVyisb0%3D 15756280 (Pubitemid 40546685)
32. P Jones P Laird 1999 Cancer epigenetics comes of age Nat Genet 21 163 167 10.1038/5947 1:CAS:528:DyaK1MXpsVClug%3D%3D 9988266 (Pubitemid 29070360)
33. S Baylin J Herman 2000 DNA hypermethylation in tumorigenesis: epigenetics joins genetics Trends Genet 16 168 174 10.1016/S0168-9525(99)01971-X 1:CAS:528:DC%2BD3cXit1Sqsbg%3D 10729832 (Pubitemid 30169152)
34. M Esteller PG Corn SB Baylin JG Herman 2001 A gene hypermethylation profile of human cancer Cancer Res 61 3225 3229 1:CAS:528:DC%2BD3MXjtFSjt7g%3D 11309270
35. L Deiss E Feinstein H Berissi O Cohen A Kimchi 1995 Identification of a novel serine/threonine kinase and a novel 15-kD protein as potential mediators of the gamma interferon-induced cell death Genes Dev 9 15 30 10.1101/gad.9.1.15 1:CAS:528:DyaK2MXjtFWqtL0%3D 7828849
36. M Sanchez-Beato A Sanchez-Aguilera MA Piris 2003 Cell cycle deregulation in B-cell lymphomas Blood 101 1220 1235 10.1182/blood-2002-07-2009 1:CAS:528:DC%2BD3sXht1agt7c%3D 12393483 (Pubitemid 36182489)
37. S Cote R Momparler 1997 Activation of the retinoic acid receptor beta gene by 5-aza-2'-deoxycytidine in human DLD-1 colon carcinoma cells Anticancer Drugs 8 56 61 10.1097/00001813-199701000-00007 1:CAS:528:DyaK2sXht1alsLw%3D 9147612 (Pubitemid 27064750)
38. A Virmani A Rathi S Zochbauer-Muller N Sacchi Y Fukuyama D Bryant, et al. 2000 Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas J Natl Cancer Inst 92 1303 1307 10.1093/jnci/92.16.1303 1:CAS:528:DC%2BD3cXmtlektrw%3D 10944551
39. LR Silverman JF Holland RS Weinberg BP Alter RB Davis RR Ellison, et al. 1993 Effects of treatment with 5-azacytidine on the in vivo and in vitro hematopoiesis in patients with myelodysplastic syndromes Leukemia 7 Suppl 1 21 29 7683352
40. L Silverman E Demakos B Peterson AB Kornblith JC Holland R Odchimar-Reissig, et al. 2002 Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B J Clin Oncol 20 2429 2440 10.1200/JCO.2002.04.117 1:CAS:528: DC%2BD38XksFakur8%3D 12011120 (Pubitemid 34525728)